Glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications used to treat type 2 diabetes and obesity, have seen a significant surge in usage in recent years. However, these drugs may potentially impact the effectiveness of oral contraceptives, leading to concerns about unintended pregnancies[1][4]. Interactions with Oral Contraceptives GLP-1 receptor agonists, such as Ozempic, Wegovy, […]